Named for the concept of “Signal to Noise,†S2N Health advises healthcare technology innovators on business and market strategy, with the goal of maximizing the value of our clients' innovations. Since its founding in 2011, S2N has worked with >80 innovative organizations all over the world, from start-ups to large multinationals, to bring critical market and commercial insights into product & pipeline decisions, business planning, product launch, fundraising, and strategic partnering and M&A (buy & sell side). S2N's emerging company clients have raised >$500M.